TELIX PHARMACEUTICALS LIMITED
ASX:TLXPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 90.2% of what they think they own, once every option and right converts.
1 cash raise in 24 months; options/rights overhang 11% of shares
TELIX PHARMACEUTICALS LIMITED's ordinary share count was 340M as of July 2026, an increase of 1.5% since September 2024. In the past 24 months, the company conducted one capital raise, issuing A$600.0M in Convertible Notes in April 2026. Options and rights on issue could convert into 37M new shares, representing 10.8% of the current share count, with the nearest expiry in June 2027; none of these are currently in the money. The company no longer lodges quarterly cash reports, so no quarterly cash balance or funding-runway figure is disclosed on that basis. No proposed securities issues are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 9 July 2026 | 2A · quoted issue | TLX : ORDINARY FULLY PAID | 339.8M | Appendix 2A |
| 9 July 2026 | 3G · unquoted | ORDINARY FULLY PAID | 339.4M | Appendix 3G |
| 9 July 2026 | 3H · cancellation | TLX : ORDINARY FULLY PAID | 339.4M | Appendix 3H |
| 1 June 2026 | 3G · unquoted | ORDINARY FULLY PAID | 339.4M | Appendix 3G |
| 7 May 2026 | 3G · unquoted | TLX : ORDINARY FULLY PAID | 339.1M | Appendix 3G |
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Condition-triggered36.7M · 10.8% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
- Converts on terms6k · 0.0% of sharesConvertibles with no exercise price — they convert on their own terms, so they are shares in all but name.
Exercise price on record: 0 priced, 15k at a stated nil price, 36.7M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
No option supply on record carries an exercise price to pay, so no share price switches any of it on. 15k of it states a NIL exercise price — nothing is paid to convert that, so it converts at any price. The other 36.7M converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| TLXAQ | Rights | Condition-triggered | Nil | 13 June 2027 | 15k | Filing Meeting |
| TLXAT | Notes | Converts on terms | — | — | 6k | Filing |
| TLXAU | Rights | Condition-triggered | — | — | 9k | Filing Meeting |
| TLXAY | Rights | Condition-triggered | — | — | 66k | Filing Meeting |
| TLXAX | Rights | Condition-triggered | — | — | 88k | Filing Meeting |
| TLXAS | Performance shares | Condition-triggered | — | — | 440k | Filing Meeting |
| TLXAZ | Rights | Condition-triggered | — | — | 457k | Filing Meeting |
| TLXAP | Rights | Condition-triggered | — | — | 1.3M | Filing Meeting |
| TLXAW | Performance shares | Condition-triggered | — | — | 8.6M | Filing Meeting |
| TLXAR | Performance rights | Condition-triggered | — | — | 10.0M | Filing Meeting |
| TLXAO | Rights | Condition-triggered | — | — | 15.9M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
- TLXAVCondition-triggered2k securities → 011 Mar 2026 Appendix 2A
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 11 June 2026 | David Gill | Buy on-market | 10k | — | — | — | 3Y notice |
| 26 May 2026 | David Gill | Other incentive | 30k | — | — | — | 3Y notice |
| 26 May 2026 | Dr Christian Behrenbruch | Other incentive | 654k | 340k | 27k | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.